BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Du ZQ, Zhao JZ, Dong J, Bi JB, Ren YF, Zhang J, Khalid B, Wu Z, Lv Y, Zhang XF, Wu RQ. Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study. World J Gastroenterol 2019; 25(28): 3798-3807 [PMID: 31391774 DOI: 10.3748/wjg.v25.i28.3798]
URL: https://www.wjgnet.com/1948-5182/full/v25/i28/3798.htm
Number Citing Articles
1
Lun-Jie Yan, Sheng-Yu Yao, Hai-Chao Li, Guang-Xiao Meng, Kai-Xuan Liu, Zi-Niu Ding, Jian-Guo Hong, Zhi-Qiang Chen, Zhao-Ru Dong, Tao Li. Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysisJournal of Clinical and Translational Hepatology 2022; 0(000): 000 doi: 10.14218/JCTH.2021.00257
2
Mengshi Yi, Xi Feng, Wei Peng, Fei Teng, Youyin Tang, Zheyu Chen. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver diseaseEuropean Journal of Clinical Pharmacology 2022;  doi: 10.1007/s00228-021-03247-1
3
Hongda Ding, Yingshi Zhang, Liang Zhao, Si Wu, Junpeng Liu, Caibin Wang, Tong Pei, Yang Su. What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysisPharmacological Research 2020; 157: 104825 doi: 10.1016/j.phrs.2020.104825
4
Tracey G. Simon, Andrew T. Chan. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 549 doi: 10.1016/j.cld.2020.06.002
5
Pamela Czajka, Adam Przybyłkowski, Anna Nowak, Marek Postula, Marta Wolska, Dagmara Mirowska-Guzel, Anna Czlonkowska, Ceren Eyileten. Antiplatelet drugs and liver fibrosisPlatelets 2021; : 1 doi: 10.1080/09537104.2021.1883574
6
Yuwei Liu, Tianqi Ren, Xiaotong Xu, Jinglan Jin. Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studiesEuropean Journal of Cancer Prevention 2022; 31(1): 35 doi: 10.1097/CEJ.0000000000000663
7
Pierluigi Ramadori, Thomas Klag, Nisar Peter Malek, Mathias Heikenwalder. Platelets in chronic liver disease, from bench to bedsideJHEP Reports 2019; 1(6): 448 doi: 10.1016/j.jhepr.2019.10.001
8
Zoe N. Memel, Ashwini Arvind, Oluwatoba Moninuola, Lisa Philpotts, Raymond T. Chung, Kathleen E. Corey, Tracey G. Simon. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta‐analysisHepatology Communications 2021; 5(1): 133 doi: 10.1002/hep4.1640
9
Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed, Mark Danta. Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2021; 54(4): 356 doi: 10.1111/apt.16515
10
Taha Ahmed, Alla Y. Grigorian, Adrian W. Messerli. Management of Acute Coronary Syndrome in Patients with Liver CirrhosisAmerican Journal of Cardiovascular Drugs 2022; 22(1): 55 doi: 10.1007/s40256-021-00478-6